Table 2.
Regression models—lab data (changes in outcome measures).
| Variable |
HbA1c β
(p-value) |
LDL β
(p-value) |
Triglyceride β
(p-value) |
Total Cholest-erol β
(p-value) |
eGFR β
(p-value) |
|---|---|---|---|---|---|
| Months in MII treatment | −0.038 (p = 0.067) |
−0.291 (p = 0.534) |
−3.115 (p = 0.035) |
−0.440 (p = 0.390) |
−0.045 (p = 0.801) |
| Male gender | −0.230 (p = 0.558) |
−14.353 (p = 0.079) |
62.776 (p = 0.013) |
2.100 (p = 0.809) |
−2.375 (p = 0.441) |
| Black/African American | −0.679 (p = 0.397) |
−40.762 (p = 0.020) |
9.659 (p = 0.858) |
−42.617 (p = 0.029) |
11.232 (p = 0.098) |
| Age (at first encounter) | |||||
| <45 years (vs. age 45–64) |
0.061 (p = 0.886) |
4.969 (p = 0.611) |
−49.157 (p = 0.102) |
3.038 (p = 0.772) |
−6.401 (p = 0.086) |
|
>65 years (vs. age 45–64) |
−0.129 (p = 0.795) |
2.873 (p = 0.790) |
−35.029 (p = 0.308) |
2.957 (p = 0.807) |
−5.552 (p = 0.198) |
| BMI category | |||||
| Mild obesity (vs. normal/overweight) |
−0.460 (p = 0.259) |
−7.07 (p = 0.444) |
2.689 (p = 0.925) |
−2.743 (p = 0.787) |
−0.672 (p = 0.853) |
| Severe obesity (vs. normal/overweight) |
−0.136 (p = 0.757) |
−1.178 (p = 0.906) |
14.180 (p = 0.648) |
−2.323 (p = 0.832) |
−6.349 (p = 0.113) |
| HbA1c control category | |||||
| Fair control (vs. good control) |
−0.033 (p = 0.939) |
N/A | N/A | N/A | N/A |
| Poor control (vs. good control) |
−1.299 (p = 0.017) |
N/A | N/A | N/A | N/A |
| Model R2 goodness of fit statistic | 0.371 | 0.188 | 0.238 | 0.143 | 0.236 |
| Model F-statistic and p-value | 3.02 (p = 0.007) |
1.46 (p = 0.208) |
2.10 (p = 0.062) |
1.12 (p = 0.368) |
1.99 (p = 0.078) |
| Number of patients w/usable data | 56 | 52 | 55 | 55 | 53 |
Bold p-values indicate statistically significant coefficients.